Celcuity Inc. (CELC) Financials
CELC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 142.4 million | 49.5 million |
2023-06-30 | 153.5 million | 43.4 million |
2023-03-31 | 164.9 million | 41.6 million |
2022-12-31 | 175.7 million | 41.9 million |
CELC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.8 million | 1.1 million |
2023-06-30 | -9.7 million | 1.3 million |
2023-03-31 | -12.9 million | 1.3 million |
2022-12-31 | -9.6 million | 1.1 million |
CELC Net Income
No data available :(
CELC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 133.9 million | - | 459025 |
2023-06-30 | 146.2 million | 36.0 million | 508453 |
2023-03-31 | 157.5 million | 35.5 million | 559837 |
2022-12-31 | 168.6 million | 35.0 million | 255200 |
CELC Shares Outstanding
CELC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 53104 | 17.5 million | 1.4 million | - |
2023-06-30 | 4854 | 13.7 million | 1.3 million | - |
2023-03-31 | 6987 | 11.3 million | 1.3 million | - |
2022-12-31 | 112044 | 10.6 million | 1.0 million | - |
CELC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 33555 |
2023-06-30 | - | 37331 |
2023-03-31 | - | 43938 |
2022-12-31 | - | 48937 |
CELC
Price: $17.66
52 week price:
Earnings Per Share: -2.74 USD
P/E Ratio: -5.28
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 28600
Market Capitalization: 499.2 million